Pharmacy Medical News about Drug Therapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
PharmacoEconomics, 09/22/09

Polsky D et al. – Addition of baseline Hb level as a variable in propensity score and ESA cost models affects ESA treatment cost estimates in patients with cancer receiving chemotherapy. Cost comparisons based on observational data should use analytical methods that account for differences in clinical variables between treatment groups.

<< Previous
Prevalence of extensively drug-resistant tuberculosis in Vladimir...

Next >>
P&T considerations in fashioning a knowledge base, action...

Emergency Influenza Drug
JAMA, 11/25/09 Relevance Score: 68%

Disparate Response to Metoclopramide Therapy for Gastric Feeding Intolerance in Trauma Patients With and Without Traumatic Brain Injury
Journal of Parenteral and Enteral Nutrition, 11/10/09 Relevance Score: 68%

Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09 Relevance Score: 68%

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
BMC Infectious Diseases, 10/20/09 Relevance Score: 68%

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09 Relevance Score: 68%